Verition Fund Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14,808	Closed	-$76K	–	1072
2019 Q1	$76K	Buy	+14,808	New	+$76K	﹤0.01%	963
2018 Q2	–	Sell	-10,195	Closed	-$48K	–	1087
2018 Q1	$48K	Buy	+10,195	New	+$48K	﹤0.01%	1026